Asparaginase Toxicities in ALL: Rapid Identification, Management, and Patient/Family Partnerships to Improve Outcomes (SY3)

Saturday, September 15
12:45 – 2 pm
CNE Presentation

Get the latest updates on current and emerging asparaginase therapies in pediatric ALL at this interactive satellite symposium. A variety of topics will be discussed, including mechanism of action and pharmacokinetics, monitoring and management of asparaginase toxicities, and communication approaches specific to pediatric patients and their families. Attendees will have the opportunity to interact with expert faculty throughout the symposium.

Learning Objectives

After successful completion of this educational activity, participants should be able to:

  • Discuss current and emerging asparaginase therapies for pediatric patients, including mechanism of action, structure, bacterial source, and pharmacokinetics.
  • Implement clinical nursing approaches for the monitoring and management of asparaginase toxicities for pediatric patients with ALL.
  • Describe best practices in patient/family education and communication to improve outcomes for pediatric patients with ALL.

Disclosures

Disclosure of Relevant Financial Relationships

prIME Oncology assesses the relevant financial relationships of its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. Any potential conflicts of interest that are identified are thoroughly vetted by prIME Oncology for fairness, balance, and scientific objectivity of data, as well as patient care recommendations. prIME Oncology is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial entity.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure Regarding Unlabeled Use

This activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration or European Medicines Agency. Please refer to the official prescribing information for each product discussed for discussions of approved indications, contraindications, and warnings.

Continuing Education

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and prIME Oncology. Postgraduate Institute for Medicine (PIM) and prIME Oncology assesses the relevant financial relationships of its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. Any potential conflicts of interest that are identified are thoroughly vetted by PIM and prIME Oncology for fairness, balance, and scientific objectivity of data, as well as patient care recommendations. PIM and prIME Oncology is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial entity.

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.2 contact hours.

Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

Provider

This activity is jointly provided by prIME Oncology and Postgraduate Institute for Medicine.

 

Please note that while this optional event is included in the conference fee, selecting the event on the registration form is required to attend. Space is limited. 

This educational activity is supported by a grant from Shire

 

Speaker:
Chair
Belinda Mandrell, PhD RN

Faculty
Katie Gettinger, MSN RN CPNP
Anna Lefebvre, MSN RN CPNP CPON®
Joan Ronan, MSN RN CPNP CPON®